| Taylor Mcarthur, RPH | |
|
2611 Harrison Ave, Butte, MT 59701-3759 | |
| (406) 782-5471 | |
| Not Available |
| Full Name | Taylor Mcarthur |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2611 Harrison Ave, Butte, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518740661 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PHA-PHA-LIC-98192 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Taylor Mcarthur, RPH 2611 Harrison Ave, Butte, MT 59701-3759 Ph: (406) 782-5471 | Taylor Mcarthur, RPH 2611 Harrison Ave, Butte, MT 59701-3759 Ph: (406) 782-5471 |
News Archive
Scientists at Karolinska Institutet in Sweden describe in a new study how so-called DNA origami can enhance the effect of certain cytostatics used in the treatment of cancer. With the aid of modern nanotechnology, scientists can target drugs direct to the tumour while leaving surrounding healthy tissue untouched.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has received the new drug approval from the State Food and Drug Administration for Iremod.
A new ADD/ADHD study found that a multi-modal hemispheric based program significantly improved the participant's educational outcomes. The study, "The Effect of Hemispheric Specific Remediation Strategies on the Academic Performance Outcome of Children With ADD/ADHD," was conducted by a research team including, Gerry Leisman, Robert Melillo, Sharon Thum, Mark Ransom, Michael Orlando, Christopher Tice, and Frederick Carrick. The study appears in the current issue of the International Journal of Adolescent Medicine and Health.
It is increasingly recognized that chronic psychotropic drug treatment may lead to structural remodeling of the brain. Indeed, clinical studies in humans present an intriguing picture: antipsychotics, used for the treatment of schizophrenia and psychosis, may contribute to cortical gray matter loss in patients, whereas lithium, used for the treatment of bipolar disorder and mania, may preserve gray matter in patients.
› Verified 4 days ago
Kevin Swanson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2500 Massachusetts Ave, Butte, MT 59701 Phone: 406-494-3754 Fax: 406-494-3823 | |
Mr. Ernest Charles Richards Jr., RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 327 S Excelsior Ave, Butte, MT 59701 Phone: 406-723-3308 | |
Katie Mcgree, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 445 Centennial Ave, Butte, MT 59701 Phone: 406-723-4075 Fax: 406-782-5060 | |
Allison Katherine Eisenzimer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2611 Harrison Ave, Butte, MT 59701 Phone: 406-782-5471 | |
Maureen Tomich, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2500 Massachuetts Ave, Butte, MT 59701 Phone: 406-494-3754 Fax: 406-494-3823 | |
Jenee Darlene Paluso, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 445 Centennial Ave, Butte, MT 59701 Phone: 406-723-4075 | |
Leslie C. Allen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 116033 Fleecer Rd, Butte, MT 59750 Phone: 406-723-9106 Fax: 406-723-9106 |